In pursuit of improved methods for development, manufacture and administration of drugs, scientists continue to explore dosage forms, compositions and drug delivery options as science and technology expands the horizon of pharma research.
Formulations and delivery methods of drugs are constantly evolving due to factors like improvements in drug bioavailability, new excipients, safer and more effective products, new regulatory requirements, advancements in processing and manufacturing techniques, etc.
In addition, the COVID-19 pandemic, one of the biggest health crises of this century, has been instrumental in advancing progress in this area.
Director - General, Pharmexcil
Independent Advisor- Life Sciences
MD, Solinova Life Sciences
Co-Founder & CEO, QbD Biosciences
Director, Adv. Drug Delivery Research & IVIVC / Biopharmaceutics, Pharma R&D, Lupin
CEO - QbD International; United Nations Adviser – Geneva
Sr President - R&D, Bharat Serums & Vaccines
VP & Head R&D, Maiva Pharma
VP & Head R&D (Formulations), Biocon Pharma
Site Head & Sr Director, Perrigo India Laboratories
Sr VP, Clinical Pharmacology Research, Viatris (Formerly as Mylan)
VP & Head - R&D, Tirupati Group
Chief Scientific Officer, Sentiss Pharma
Head - R&D, Beximco Pharmaceuticals, Bangladesh
VP - Formulations, Mankind Pharma
Sr VP, MSN Laboratories
AVP, Innovation & Science, Amway
Principal Advisor, Institute of Good Manufacturing Practices India (IGMPI)
CTO, Indoco Remedies
Professor & Head, Technology & Translation Laboratory, School of Biotechnology, KIIT University, Bhubaneshwar
Asst Drugs Controller (I), Biologicals Div, CDSCO
MD, Ideal Cures
GM, Ideal Cures
Technical Account Specialist, West Pharmaceutical Services, India
Field Marketing Manager - Particle Counting & Characterization - Europe, Beckman Coulter Life Sciences